Technical / White Paper
FDA Focus̶ Product Design and Post Approval Changes
Review a new Colorcon Technical Paper offering a summary of key points presented in the recent US Center for Drug Evaluation and Research (CDER) Guidance for manufacturers “Safety Considerations for Product Design to Minimize Medication Errors in Drug Product Development”. Gain insight on the regulators perspective to reduce the risk of delays for your product development …appreciate the impact of the FDA Guidance for Industry
